You need to do more research on that....Far more money raised...

You need to do more research on that....Far more money raised over years @antibotter,

From 2021....https://www.profoundbio.com/News-Detail?article_id=14

About ProfoundBioProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on innovative technology platforms, ProfoundBio has developed a pipeline consisting of multiple solid tumor-targeting drug candidates that are currently in discovery and preclinical development stages. ProfoundBio has operations in both the greater Seattle area, WA, USA and Suzhou, China.

About Lilly Asia VentureLilly Asia Ventures (LAV) is a leading biomedical venture capital firm, with offices in Shanghai, Hong Kong, and Palo Alto. As one of the earliest biomedical venture investors in China, LAV has been consistently investing in this region for over a decade. With a team of over 30 distinguished scientific, medical, investment, and operational professionals, LAV manages over $4.5 billion of committed capital. LAV's vision is to become the trusted partner for exceptional entrepreneurs seeking smart capital and to build great companies developing breakthrough products that treat diseases and improve human health.

About LYFE CapitalFounded in 2015, LYFE Capital is a dedicated healthcare fund, with two offices set up in Shanghai, China and Menlo Park, US. We are actively seeking healthcare companies with exceptional management teams and expansive vision geared towards global markets. Our investment focus spans innovative biopharmaceuticals, medical devices, and diagnostics. We work closely with our portfolio companies to support their needs by providing capital and active support in global partnerships, collaborations, strategy, regulatory guidance and local market access. At LYFE Capital, our portfolio companies are not just investments, but rather long-term partners.

About Sequoia ChinaThe Sequoia team helps daring founders build legendary companies. In partnering with Sequoia, companies benefit from our unmatched community and the lessons we've learned over 49 years. As "The Entrepreneurs Behind the Entrepreneurs," Sequoia China focuses on three sectors: TMT, consumer/services and healthcare. Over the past 16 years we've had the privilege of working with approximately 600 companies in China.

About OrizaSuzhou Oriza Holdings Corporation (hereinafter referred to as "Oriza Holdings") is an investment holding company with over RMB 100 billion under management. Its businesses cover equity investment, debt financing and investment & financing services. Oriza Holdings has achieved a great success in exploring financial creation, boosting science creation, guiding fund accumulation and upgrading industries through the coordination of the three businesses of capital operation, risk control and operation allocation, including China' s first national FOFs of equity investment etc.